| Literature DB >> 34179271 |
Tatiana Jofra1, Giuseppe Galvani1, Fousteri Georgia1, Gregori Silvia2, Nicola Gagliani3,4, Manuela Battaglia1.
Abstract
Type 1 diabetes (T1D) is an autoimmune disease caused by the lack of insulin-producing pancreatic beta cells leading to systemic hyperglycemia. Pancreatic islet transplantation is a valid therapeutic approach to restore insulin loss and to promote adequate glycemic control. Pancreatic islet transplantation in mice is an optimal preclinical model to identify new therapeutic strategies aiming at preventing rejection and optimizing post-transplant immuno-suppressive/-tolerogenic therapies. Islet transplantation in preclinical animal models can be performed in different sites such the kidney capsule, spleen, bone marrow and pancreas. This protocol describes murine islet transplantation under the kidney capsule. This is a widely accepted procedure for research purposes. Stress caused in the animals is minimal and it leads to reliable and reproducible results.Entities:
Keywords: Islet transplantation; Murine model; Pancreatic islets; Type 1 diabetes
Year: 2018 PMID: 34179271 PMCID: PMC8203884 DOI: 10.21769/BioProtoc.2743
Source DB: PubMed Journal: Bio Protoc ISSN: 2331-8325